A comparative analysis on the safety and efficacy of Covaxin versus other vaccines against COVID-19: a review.

Talukder, Abhijita; Kalita, Chayanika; Neog, Nayanika; Goswami, Chayanika; Sarma, Mrinal Kashyap; Hazarika, Iswar

Talukder, Abhijita; Kalita, Chayanika; Neog, Nayanika; Goswami, Chayanika; Sarma, Mrinal Kashyap; Hazarika, Iswar.

Afiliação

Talukder A; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.
Kalita C; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.
Neog N; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.
Goswami C; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.
Sarma MK; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.
Hazarika I; Department of Pharmacology, Girijananda Chowdhury Institute of Pharmaceutical Science, Guwahati 781017, India.

Z Naturforsch C J Biosci ; 77(7-8): 351-362, 2022 Jul 26.

Article em En | MEDLINE | ID: mdl-35245422

Assuntos

COVID-19; Vacinas; COVID-19/prevenção & controle; Vacinas contra COVID-19/efeitos adversos; Humanos; Pandemias/prevenção & controle; SARS-CoV-2

Palavras-chave

COVAXIN; SARS-CoV-2; WHO EUL list; herd immunity; vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Z Naturforsch C J Biosci Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google